THEMISMED and IOLCP rewarded by CARE Ratings for its improved performance

CARE Ratings Limited ('CARE') has upgraded long term credit rating on the company's bank facilities to B+ Stable, from B Stable for Themis Medicare and A+ Stable from A Stable for IOL chemical & pharmaceuticals.

Themis Medicare :

Themis Medicare Limited is engaged in manufacturing pharmaceuticals and medicinal chemicals, such as formulations and active pharmaceutical ingredients.

Companies Net Sales Up 33.84% by Rs 61.77 crore in March 2021 from Rs.46.15 crore in March 2020. Quarterly Net profit up 10.67 % by Rs.8.05 crore in March 2021 from Rs.7.28 crore in March 2020. EBITDA down 4.65 % by Rs.13.13 crore in March 2021 from Rs.13.77 crore in March 2020. EPS has increased to Rs. 8.76 in March 2021 from Rs. 7.92 in March 2020.

IOL chemical & pharmaceuticals:

IOL Chemicals and Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in manufacturing and selling of organic chemicals and bulk drugs.

Companies Net Sales up 17% by Rs. 460.38 crore in March 2021 from Rs.441.46 crore in March 2020. Quarterly Net profit down 17% by Rs.75 crore in March 2021 from Rs.90 crore in March 2020. EBITDA down 18% by Rs.117 crore in March 2021 from Rs.142 crore in March 2020. EPS has decreased to Rs. 12.76 in March 2021 from Rs. 15.87 in March 2020.